Invenire Partners »

Inotiv shares owned by Invenire Partners

Quarter-by-quarter ownership of Inotiv (NOTV) shares owned by Invenire Partners from 13F filings

Historical chart of Invenire Partners investment in Inotiv

Tip: Access up to 7 years of quarterly data

All positions including Inotiv held by Invenire Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inotiv by Invenire Partners

Quarter filed Position value Share count Share price at filing
2022-09-30 $1.6M 95k 16.85

More positions owned by Invenire Partners

Harrow Health (HROW)
Dhi (DHX)
TETRA Technologies (TTI)
Apyx Medical Corporation (APYX)
InfuSystem Holdings (INFU)
The Arena Group Holdings (AREN)
Cantaloupe (CTLP)
PAR Technology Corporation (PAR)
Limelight Networks
Marcus Corporation (MCS)
Docgo (DCGO)
Now (DNOW)
Everi Hldgs (EVRI)
Primoris Services (PRIM)
CryoLife (AORT)

View all positions for Invenire Partners

Top funds holding Inotiv

Vanguard Group
Balyasny Asset Management
Renaissance Technologies
Vantage Point Financial
Geode Capital Management
UBS Group
BlackRock
Citadel Advisors
GSA Capital Partners
Morgan Stanley
Jane Street
KPP Advisory Services
Acorn Creek Capital
EHP Funds
Mount Lucas Management Corporation

View all funds holding Inotiv